You are here: Home » International » News » Others
Business Standard

Pentagon, US companies involved in Ukraine military biolabs: Russia

The head of Russia's Investigative Committee, Alexander Bastrykin has said that his team is making progress in a criminal probe into Ukraine's alleged Pentagon-funded bioweapons programme.

Topics
Russia Ukraine Conflict | United States | Pentagon

IANS  |  Moscow 

Pentagon
(Photo: Bloomberg)

The head of Russia's Investigative Committee, Alexander Bastrykin has said that his team is making progress in a criminal probe into Ukraine's alleged Pentagon-funded bioweapons programme.

"The analysis of the obtained documents allowed us to clearly identify the people involved in the military biological activities in Ukraine, including representatives of the US Department of Defense and American companies with ties to it," he said, RT reported.

Bastrykin added that the US had spent more than $224 million on biological programmes in Ukraine since 2005 and the foreign aid was used to equip and upgrade around 30 research centers governed by Ukraine's Defence, Health and Agriculture ministries.

"The results of said research had been evacuated to Kiev-controlled territory before the start of (Russia's) special military operation," he said, adding that his agency would continue to study the documents on the matter.

In March, Moscow claimed that it had found evidence that the US had been funding biological weapons research in Ukraine. Washington and Kiev denied this claim and accused Russia of waging a disinformation campaign, RT reported.

Senior US diplomat Victoria Nuland said at the time that Washington was working with Ukraine to prevent research materials from falling into the hands of Russian troops.

Chinese Foreign Ministry spokesman Zhao Lijian, meanwhile, urged the US to "give a full account of its biological military activities at home and abroad and subject itself to multilateral verification".

--IANS

san/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, May 03 2022. 19:51 IST
RECOMMENDED FOR YOU